Investor Relations

The investor pages that follow are your resource for financial information about Osiris Therapeutics. In this section you will find information about our current and historical share price, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Recent Releases

Osiris Announces Receipt of $15 Million Cash Payment for Prochymal

Osiris Therapeutics Announces Therésa K. Dixon as General Manager of Market Access and Reimbursement

more »


2nd Annual Regen Med Investor Day

Osiris Therapeutics Fourth Quarter and Full Year 2013 Earnings Conference Call and Webcast

more »

©2014 Osiris Therapeutics, Inc. • 7015 Albert Einstein Drive • Columbia, MD • 21046 • p(443) 545-1800 Legal Notice